logo

GCircular Dichroism Spectrometers Market Size (2024 - 2029)

The circular dichroism spectrometers market is projected to experience significant growth, driven by increased research and development activities, particularly in the biopharmaceutical sector. The pandemic initially hindered progress due to lockdowns, but the subsequent surge in research for COVID-19 treatments, including vaccine development, boosted demand for these spectrometers. The expanding use of biologics in treating chronic and rare diseases further propels market expansion, supported by substantial investments from both public and private sectors. Despite these growth drivers, a shortage of skilled professionals may pose challenges to market expansion.

Home Market Analysis Healthcare Research Medical Devices Research Medical Imaging Research Diagnostic Imaging Research Medical Optical Imaging Research Spectroscopy Research GCircular Dichroism Spectrometers Market Market Size

Market Size of GCircular Dichroism Spectrometers Industry

Circular Dichroism Spectrometers Market Size
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
CAGR (2024 - 2029) 6.50 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

GCircular Dichroism Spectrometers Market Major Players

*Disclaimer: Major Players sorted in no particular order

Circular Dichroism Spectrometers Market Analysis

The GCircular Dichroism Spectrometers Market is expected to register a CAGR of 6.5% during the forecast period(2024-2029).

  • The COVID-19 pandemic significantly impacted the market initially due to the lockdown restrictions imposed by the countries to control the spread of the virus, thereby impacting research and development activities. But during the late pandemic, very intensive research and development activities were started to find a cure for SARS-CoV-2 virus infection in which circular dichroism spectrometers were also used for the understanding of the molecular structure and chiral activities of biomolecules such as protein and DNA. 
  • For instance, according to the research study published in June 2021 in NCBI, circular dichroism is a common technique in biochemistry, structural biology, and pharmaceutical chemistry, and it is a widely used method for examining the structures and conformational changes of proteins. Therefore, the outbreak of the pandemic increased research activities, which in turn propelled the demand for circular dichroism spectrometers. Thus, the market witnessed considerable growth during the pandemic. Furthermore, the market has seen a surge post-pandemic due to the increased adoption of circular dichroism spectrophotometers in the development of vaccines for COVID-19.
  • The increasing popularity of biologics and increasing investments by private and public sectors in the R&D of biopharmaceuticals are the major factors propelling the market growth. The circular dichroism spectrometers are used in the study of molecular structure and chiral activities of biomolecules, and their use is expected to increase with the growing popularity and usage of biopharmaceuticals or biologics (for example, vaccines, gene and cellular therapies, fusion proteins, insulin, interferon, and monoclonal antibody (mAb) among others) that are used in the treatment of various chronic and rare diseases.
  • For instance, according to the April 2022 report of the American Cancer Society, biologics are used in the treatment of cancer in many ways and are being used widely for the treatment. Furthermore, in June 2022, Amgen Inc. received approval for RIABNI (rituximab-Marx), a biosimilar to Rituxan, from the United States Food and Drug Administration for adults with moderate to severely active rheumatoid arthritis (RA) who have had an inadequate response to one or more tumor necrosis factor (TNF) antagonist therapies in combination with methotrexate. Hence, the growing usage of biologics drugs and their potential in treating various diseases is expected to increase intensive research and development activities, where circular dichroism spectrometers are used in the analysis of biomolecules, and thus, the demand for circular dichroism spectrometers is expected to increase over the forecast period that is expected to boost growth in the studied market.
  • Moreover, the growing research and development activities, along with new investments in the area by the government as well as private entities, are expected to fuel growth in the circular dichroism spectrometers market over the forecast period. For instance, in August 2022, Innovent Biologics of China and Paris-based Sanofi would invest USD 2.42 billion in the biopharma group to jointly develop two cancer drugs in China. As per Innovent Biologics, SAR408701, or tusamitamab ravtansine, would be used to treat lung, gastric, and other cancers, while SAR444245, or non-alpha IL-2, was under phase-II studies for skin cancer, head, and neck tumors, among others.
  • In addition, in June 2022, the Rare Disease division of AstraZeneca, Alexion, spent about EUR 65 million (USD 68.6 million) to expand its manufacturing capabilities in Ireland, and over the next 18 months, the investment will be used by the company to build up its biologics manufacturing capacity and increase research and development initiatives in the country. Therefore, due to the above-mentioned factors, the demand for circular dichroism spectrometers is expected to increase; thereby considerable market growth is anticipated over the forecast period.
  • Therefore, the rising investments in the development of biologics and biopharmaceuticals, along with the increasing investments by private and public sectors in R&D, are the factors expected to drive the market growth. However, the lack of skilled professionals is expected to restrain the growth of the circular dichroism spectrometers market over the forecast period.

Circular Dichroism Spectrometers Industry Segmentation

A circular dichroism spectrometer is an analytical instrument used to study the molecular structure and chiral activities of biomolecules such as protein and DNA. 

The circular dichroism spectrometers market is segmented by product (linearly polarized light sources, circularly polarized light sources, and multiple light sources), end-user (pharmaceutical industry, government and private research organizations, and others), and geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across major regions globally. 

The report offers the value (in USD) for the above segments.

By Product
Linearly Polarized Light Sources
Circularly Polarized Light Sources
Multiple Light Sources
By End-User
Pharmaceutical Industry
Government and Private Research Organizations
Other End-Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

GCircular Dichroism Spectrometers Market Size Summary

The circular dichroism spectrometers market is poised for significant growth, driven by the increasing demand for these instruments in the biopharmaceutical sector. The market experienced a notable boost during the COVID-19 pandemic as researchers utilized circular dichroism spectrometers to understand the molecular structures of biomolecules, aiding in vaccine development. This trend has continued post-pandemic, with the rising popularity of biologics and substantial investments in biopharmaceutical research and development further propelling market expansion. The pharmaceutical industry, a major end-user, is expected to contribute significantly to market growth due to its intensive R&D activities and the critical role of circular dichroism spectrometers in the analytical development of biopharmaceuticals.

The market landscape is characterized by a few key players, including Jasco, Applied Photophysics Ltd., and Bruker, among others, who hold significant market shares. The competitive environment is shaped by ongoing investments and collaborations aimed at advancing drug research and development. For instance, Pfizer's establishment of a global drug research center in India and ABVC BioPharma's funding agreement highlight the industry's commitment to innovation. Despite the promising growth prospects, the market faces challenges such as a shortage of skilled professionals, which could potentially hinder its expansion. Overall, the circular dichroism spectrometers market is expected to witness considerable growth, supported by technological advancements and increasing demand from the pharmaceutical and biopharmaceutical sectors.

Explore More

GCircular Dichroism Spectrometers Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Popularity of Biologics

      2. 1.2.2 Increasing Investments by Private and Public Sectors in R&D of Biopharmaceuticals

    3. 1.3 Market Restraints

      1. 1.3.1 Requirement of Specialized Infrastructure and Skilled Operators

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD)

    1. 2.1 By Product

      1. 2.1.1 Linearly Polarized Light Sources

      2. 2.1.2 Circularly Polarized Light Sources

      3. 2.1.3 Multiple Light Sources

    2. 2.2 By End-User

      1. 2.2.1 Pharmaceutical Industry

      2. 2.2.2 Government and Private Research Organizations

      3. 2.2.3 Other End-Users

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 United Kingdom

        3. 2.3.2.3 France

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Spain

        6. 2.3.2.6 Rest of Europe

      3. 2.3.3 Asia-Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 Japan

        3. 2.3.3.3 India

        4. 2.3.3.4 Australia

        5. 2.3.3.5 South Korea

        6. 2.3.3.6 Rest of Asia-Pacific

      4. 2.3.4 Middle-East and Africa

        1. 2.3.4.1 GCC

        2. 2.3.4.2 South Africa

        3. 2.3.4.3 Rest of Middle-East and Africa

      5. 2.3.5 South America

        1. 2.3.5.1 Brazil

        2. 2.3.5.2 Argentina

        3. 2.3.5.3 Rest of South America

GCircular Dichroism Spectrometers Market Size FAQs

The GCircular Dichroism Spectrometers Market is projected to register a CAGR of 6.5% during the forecast period (2024-2029)

Jasco, Applied Photophysics Ltd, On-Line Instrument Systems, Inc, Bruker Corporation and Bio-Logic Science Instrument, Inc are the major companies operating in the GCircular Dichroism Spectrometers Market.

GCircular Dichroism Spectrometers Market Report Snapshots

Circular Dichroism Spectrometers Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)